Correlations between Transmembrane 4 L6 Family Member 5 (TM4SF5), CD151, and CD63 in Liver Fibrotic Phenotypes and Hepatic Migration and Invasive Capacities

• Minkyung Kang,

  Affiliations Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, Republic of Korea, Department of Pharmacy, Research Institute of Pharmaceutical Sciences, Medicinal Bioconvergence Research Center, Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul, Republic of Korea

  ⨯
• Jihye Ryu,

  Affiliation Department of Pharmacy, Research Institute of Pharmaceutical Sciences, Medicinal Bioconvergence Research Center, Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul, Republic of Korea

  ⨯
• Doohyung Lee,

  Affiliation Department of Pharmacy, Research Institute of Pharmaceutical Sciences, Medicinal Bioconvergence Research Center, Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul, Republic of Korea

  ⨯
• Mi-Sook Lee,

  Affiliation Department of Pharmacy, Research Institute of Pharmaceutical Sciences, Medicinal Bioconvergence Research Center, Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul, Republic of Korea

  ⨯
• Hye-Jin Kim,

  Affiliation Department of Pharmacy, Research Institute of Pharmaceutical Sciences, Medicinal Bioconvergence Research Center, Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul, Republic of Korea

  ⨯
• Seo Hee Nam,

  Affiliation Interdisciplinary Program in Genetic Engineering, Seoul National University, Seoul, Republic of Korea

  ⨯
• Haeng Eun Song,

  Affiliation Department of Pharmacy, Research Institute of Pharmaceutical Sciences, Medicinal Bioconvergence Research Center, Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul, Republic of Korea

  ⨯
• Jungeun Choi,

  Affiliation Interdisciplinary Program in Genetic Engineering, Seoul National University, Seoul, Republic of Korea

  ⨯
• Gyu-Ho Lee,

  Affiliation Department of Pharmacy, Research Institute of Pharmaceutical Sciences, Medicinal Bioconvergence Research Center, Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul, Republic of Korea

  ⨯
• Tai Young Kim,

  Affiliation Department of Pharmacy, Research Institute of Pharmaceutical Sciences, Medicinal Bioconvergence Research Center, Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul, Republic of Korea

  ⨯
• Hansoo Lee,

  Affiliation Department of Biological Sciences, Kangwon National University, Chunchon, Kangwon-do, Republic of Korea

  ⨯
• Sang Jick Kim,

  Affiliation Therapeutic Antibody Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejon, Republic of Korea

  ⨯
• Sang-Kyu Ye,

  Affiliation Department of Biomedical Sciences, College of Medicine, Seoul National University, Seoul, Republic of Korea

  ⨯
• Semi Kim,

  Affiliation Department of Biological Sciences, Kangwon National University, Chunchon, Kangwon-do, Republic of Korea

  ⨯
• Jung Weon Lee

  * E-mail: jwl@snu.ac.kr

  Affiliations Department of Pharmacy, Research Institute of Pharmaceutical Sciences, Medicinal Bioconvergence Research Center, Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul, Republic of Korea, Interdisciplinary Program in Genetic Engineering, Seoul National University, Seoul, Republic of Korea

  ⨯